Compound library / Tanning / Libido

Melanotan II

Pan-melanocortin agonist (MC1R/MC3R/MC4R/MC5R) explored for skin pigmentation and libido effects via central dopaminergic activity.

CategoryTanning / Libido
Regulatory standingNot an approved medicine
Typical routeSubcutaneous
Half-life~1-2 hours
Common dose range0.1-0.25 mg/day loading, then 0.5-1 mg 1-2x/week maintenance
Typical cycle lengthLoading phase then maintenance

BioHack Track models Melanotan II at a half-life of 1.5 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

Not an approved medicine

The FDA has listed this substance for evaluation as a bulk drug substance in pharmacy compounding, which is a record that it is not an approved medicine. There is no approved human dose. The range below comes from published literature and community practice.

Reconstitution

Reconstitute with bacteriostatic water.

Storage

Refrigerate after reconstitution.

Cautions

Associated with nausea, flushing, and rare reports of new moles/darkening lesions — dermatologic monitoring advised.

Track Melanotan II in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Tanning / Libido

Look up the research

These open a search of each database for Melanotan II — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support